Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023April 30, 2024 ASX-listed Bioxyne has released its first annual report since it acquired Breathe Life Sciences (BLS) in […]
